EUVIMEDEUVIMED entdecken
Kohortenstudie

Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study

Guo Ji, Sen Liu, Jindong Wan, Yaqiong Zhou iD, Changqiang Yang, Xinquan Wang, Gaomin He, Anping Zeng, Lingling Zhang, Tao Luo, Yi Yang, Dan Wang und 3 weitere

American Journal of Hypertension · 14.08.2025 · 38 (9) · 675-685

DOI: 10.1093/ajh/hpaf077 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift American Journal of Hypertension, online erschienen am 06.05.2025. Verfasst von Guo Ji und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, China. Hauptthemen laut MEDLINE: Hyperaldosteronism, Blood Pressure, Adrenal Glands, Embolization, Therapeutic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Adrenal artery embolization (AAE) has been shown to reduce blood pressure (BP) and correct biochemical abnormalities in patients with idiopathic hyperaldosteronism (IHA) during short-term 6–12-month follow-ups. This study aimed to evaluate the long-term efficacy and safety of unilateral AAE over a 24-month period. METHODS The prospective study included 109 IHA patients undergoing unilateral AAE, with 94 completing the 24-month follow-up. Evaluations included office, home and 24-hour ambulatory BP, biochemical markers, renal function, and cardiac function (echocardiography). Medication use and adverse events were documented. RESULTS At the 24-month follow-up, the office, home, and 24-hour ambulatory systolic BP values decreased by 17.3 ± 23.1, 16.4 ± 21.9, and 9.9 ± 18.6 mmHg, respectively (all P < 0.001), and the diastolic BP values decreased by 8.8 ± 16.1, 7.1 ± 15.8, and 6.4 ± 11.1 mmHg (all P < 0.001). The complete and partial clinical success rates were 14.9% and 50.0%, respectively, whereas those for biochemical success were 13.6% and 45.5%. Abnormal biochemical characteristics, including elevated plasma aldosterone levels, increased aldosterone‒renin ratios (ARRs), plasma renin suppression, and hypokalemia, were significantly improved (all P < 0.01). Improvements in cardiac remodeling and left ventricular (LV) diastolic function were observed, particularly in those with elevated LV mass index (P < 0.05). No evidence of renal impairment or long-term safety concerns was observed. CONCLUSION Unilateral AAE in IHA patients promotes sustained BP reduction, biochemical correction, improved cardiac remodeling, and enhanced LV diastolic function over 24 months, with no significant long-term safety concerns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperaldosteronismBlood PressureAdrenal GlandsEmbolization, TherapeuticHumansMaleFemaleMiddle AgedProspective StudiesAdultTreatment OutcomeTime FactorsAldosterone

Stichwörter der Autor:innen

adrenal artery embolizationblood pressurecardiac remodelinghypertensionidiopathic hyperaldosteronismlong-term outcomes

Substanzen

Aldosterone

Autor:innen und Institutionen

  • Department of Cardiology, School of Clinical Medicine, The First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan 610500, China.
  • Key Laboratory of Aging and Vascular Homeostasis at Chengdu Medical College of Sichuan Province, Chengdu, Sichuan, China.
  • Clinical Research Center for Geriatrics of Sichuan Province, Chengdu, Sichuan, China.
  • School of Clinical Medicine, Chengdu Medical College, Chengdu, Sichuan, China.

ORCID-Profile: Yaqiong Zhou, Peijian Wang

Zitieren

APA

Ji, G., Liu, S., Wan, J., Zhou, Y., Yang, C., Wang, X., He, G., Zeng, A., Zhang, L., Luo, T., Yang, Y., Wang, D., Feng, K., Hou, J., & Wang, P. (2025). Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study. American Journal of Hypertension, 38(9), 675-685. https://doi.org/10.1093/ajh/hpaf077

Vancouver

Ji G, Liu S, Wan J, Zhou Y, Yang C, Wang X, et al. Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study. American Journal of Hypertension. 2025;38(9):675-685. doi:10.1093/ajh/hpaf077

BibTeX
@article{Ji2025,
  author = {Ji, Guo and Liu, Sen and Wan, Jindong and Zhou, Yaqiong and Yang, Changqiang and Wang, Xinquan and He, Gaomin and Zeng, Anping and Zhang, Lingling and Luo, Tao and Yang, Yi and Wang, Dan and Feng, Kaige and Hou, Jixin and Wang, Peijian},
  title = {Long-term Efficacy and Safety of Unilateral Adrenal Artery Embolization in Patients with Idiopathic Hyperaldosteronism: A 24-month Cohort Study},
  journal = {American Journal of Hypertension},
  year = {2025},
  volume = {38},
  number = {9},
  pages = {675--685},
  doi = {10.1093/ajh/hpaf077}
}
Kostenlos starten →